Bemotrizinol UV Filter by DSM-Firmenich: New path into the US sunscreen market

Responsible: ad hoc news Lifestyle & Consumer Desk. Reviewed prior to publication on June 12, 2026 at 9:38:52 PM ET. Details in the imprint.

The ultraviolet filter bemotrizinol, marketed globally by DSM-Firmenich for use in sunscreens, is moving into the spotlight for US consumers after the US Food and Drug Administration (FDA) cleared it for use in domestic sunscreen products. For years, this organic UV absorber has been a staple in Europe, Asia, and Australia, where it is valued for its strong, broad-spectrum protection and photostability. With regulatory barriers now easing, US brands can start formulating next-generation sunscreens that use bemotrizinol to deliver higher and more durable UVA protection, potentially reshaping the premium segment of the sun care aisle. For DSM-Firmenich, the development opens an additional lifestyle-oriented revenue stream in a large and still growing US sun protection market.

What DSM-Firmenich’s bemotrizinol does in modern sunscreen formulas

Bemotrizinol is a chemical UV filter designed to absorb both UVA and UVB radiation, helping to prevent sunburn and long-term skin damage when incorporated into topical sunscreen products. In international markets, DSM-Firmenich supplies the ingredient as a key component for skin care brands that want broad-spectrum coverage with good formulation flexibility, especially in higher SPF products aimed at daily wear or intense sun exposure. According to reports shared around the FDA decision, the filter has been in use for decades outside the United States, supporting its safety profile when used as directed in cosmetic formulations. That long track record gives formulators a substantial body of practical data on stability, compatibility with emollients and other filters, and real-world performance in consumer products.

A technical advantage of bemotrizinol is its high photostability compared with some legacy UV filters like avobenzone, which can degrade under sunlight unless stabilized by other ingredients. Industry literature describes bemotrizinol as highly efficient at covering the long UVA range, which is associated more strongly with skin aging and some types of skin cancer risk when compared with UVB. This means formulators can potentially achieve high UVA protection ratings (such as PA-values used in Asian markets or critical wavelength benchmarks in Western markets) without overloading the formula with multiple overlapping filters. While the exact INCI labeling and allowable concentrations in the United States will follow FDA rulemaking details, international precedents show that bemotrizinol is typically used alongside other filters to balance coverage, aesthetics, and regulatory concentration caps.

For consumers, the practical effect of a filter like bemotrizinol is less about the chemical name and more about how the finished sunscreen behaves: more stable protection over time, better coverage of deeper-penetrating UVA rays, and a smoother texture when paired with modern emollients and film formers. Global formulations using DSM-Firmenich’s UV filters often focus on lightweight, non-greasy textures suited for daily facial use, including under makeup. As US brands adopt bemotrizinol, shoppers are likely to see a new wave of sunscreens marketed for high UVA defense and photoaging prevention, with positioning that overlaps skin care and dermatological protection.

US availability will depend on how quickly sunscreen manufacturers update or launch product lines that incorporate bemotrizinol, but the FDA clearance means that future products containing DSM-Firmenich’s ingredient can be developed for US shelves. Historically, DSM-Firmenich sells its UV filters business-to-business to personal care manufacturers rather than directly to consumers, so American shoppers will encounter bemotrizinol via branded sunscreens from established skin care and dermocosmetic labels sold at pharmacies, supermarkets, specialty beauty retailers, and major online platforms. Marketing materials are likely to highlight terms such as "broad-spectrum", "advanced UVA protection", and "photo-stable filter technology" rather than the molecule’s name, but ingredient savvy consumers may look for bemotrizinol or its INCI designation on the back label over time.

The broader sun care market context amplifies the relevance of this ingredient for US buyers. Dermatology organizations in the United States increasingly stress the importance of UVA protection for everyday exposure, not only beach use, particularly as concerns about photoaging, pigmentation, and skin cancer grow in public awareness. This has led to rising demand for daily wear SPF moisturizers, tinted sunscreens, and hybrid skin care-SPF products, a segment where high-performance filters like bemotrizinol can support elegant, cosmetically acceptable formulas. As more US consumers seek out lightweight textures that do not leave a white cast, chemical filters with strong UVA performance are particularly valuable for brands trying to differentiate their offerings beyond basic SPF numbers.

From a portfolio perspective, DSM-Firmenich positions its sun care ingredients as part of a broader personal care and beauty solutions suite that also includes vitamins, bioactives, and fragrance components. The company has long used its expertise in nutrition and health to support claims-driven beauty and care products, and UV filters like bemotrizinol fit into that strategy by addressing skin health and protection needs. Globally, UV filter ingredients contribute to DSM-Firmenich’s exposure to consumer trends in wellness, anti-aging, and outdoor lifestyles, even though the products themselves are sold through brand owners rather than under the DSM-Firmenich name. For consumers watching the product landscape, the arrival of bemotrizinol-enabled sunscreens in the US could signal a gradual shift toward formulas more closely aligned with those already common in Europe and Asia.

For DSM-Firmenich as a company, expanding access to its UV filter portfolio in the United States supports its positioning at the intersection of health, nutrition, and beauty. While the firm does not disclose detailed revenue by individual cosmetic ingredient, personal care and beauty solutions are part of its specialty portfolio alongside nutrition-focused businesses. Shares of DSM-Firmenich (CH1216478797, ticker DSFIR) most recently traded on Euronext Amsterdam; US investors typically access the stock via European listings rather than a primary NYSE or Nasdaq listing.

This article was created with a.i. assistance and editorially reviewed. Product information is provided without warranty; prices and availability may change at any time. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.